We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGL icon
4401
Treasure Global
TGL
$4.16M
$4.33K ﹤0.01%
1,108
-401
-27% -$1.67K
PLBY icon
4402
Playboy Inc
PLBY
$123M
$4.32K ﹤0.01%
3,544
-1,327
-27% -$2.01K
GRI
4403
GRI Bio
GRI
$4.48M
$4.31K ﹤0.01%
2,434
+1,374
+130% +$3.04K
FBIO icon
4404
Fortress Biotech
FBIO
$76M
$4.3K ﹤0.01%
1,404
-9,091
-87% -$23.4K
CVKD icon
4405
Cadrenal Therapeutics
CVKD
$4.1M
$4.28K ﹤0.01%
1,282
+889
+226% +$4.22K
MOO icon
4406
VanEck Agribusiness ETF
MOO
$1.22B
$4.28K ﹤0.01%
54
+51
+1,700% +$4.15K
HEI icon
4407
HEICO Corp
HEI
$43.1B
$4.28K ﹤0.01%
12
-177
-94% -$53.8K
POLA icon
4408
Polar Power
POLA
$5.65M
$4.26K ﹤0.01%
2,352
+2,351
+235,100% +$4.29K
LFT
4409
Lument Finance Trust
LFT
$27.3M
$4.26K ﹤0.01%
463
-933
-67% -$10.6K
ACXP icon
4410
Acurx Pharmaceuticals
ACXP
$5.84M
$4.25K ﹤0.01%
2,744
+1,713
+166% +$3.56K
MKC.V icon
4411
McCormick & Company Voting
MKC.V
$13.2B
$4.24K ﹤0.01%
84
-259
-76% -$12.7K
CULP icon
4412
Culp Inc
CULP
$45.3M
$4.23K ﹤0.01%
1,365
-965
-41% -$3.01K
CALC icon
4413
CalciMedica
CALC
$11.9M
$4.23K ﹤0.01%
821
+417
+103% +$1.48K
CTM icon
4414
Castellum
CTM
$59.6M
$4.23K ﹤0.01%
+5,872
New +$4.18K
SKIN icon
4415
SkinHealth Systems
SKIN
$86.5M
$4.22K ﹤0.01%
6,098
-23,330
-79% -$17.8K
ALZN icon
4416
Alzamend Neuro
ALZN
$8.83M
$4.22K ﹤0.01%
3,517
-2,667
-43% -$2.96K
IMMP
4417
Immutep
IMMP
$38.8M
$4.22K ﹤0.01%
10,119
-5,678
-36% -$2.47K
BH.A icon
4418
Biglari Holdings Class A
BH.A
$1.1B
$4.21K ﹤0.01%
2
-36
-95% -$59.1K
USIG icon
4419
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$4.21K ﹤0.01%
+82
New +$4.2K
ADGM
4420
Adagio Medical Holdings
ADGM
$4.33M
$4.21K ﹤0.01%
6,454
+4,252
+193% +$4.16K
RNAZ icon
4421
TransCode Therapeutics
RNAZ
$28.6M
$4.2K ﹤0.01%
677
+449
+197% +$3.05K
POAS
4422
Phaos Technology Holdings (Cayman) Ltd
POAS
$2.76M
$4.18K ﹤0.01%
+15,000
New +$23.2K
COCP icon
4423
Cocrystal Pharma
COCP
$22.5M
$4.18K ﹤0.01%
3,984
-264
-6% -$325
BRN icon
4424
Barnwell Industries
BRN
$13.6M
$4.14K ﹤0.01%
+4,102
New +$4.46K
CENN icon
4425
Cenntro
CENN
$10.9M
$4.11K ﹤0.01%
1,153
+1,001
+659% +$4.34K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.